Updated: Fri, 10/11/2024 - 12:00

Campus/building access, classes and work will return to usual conditions, as of Saturday, Oct. 12. See Campus Public Safety website for details.


Accès au campus et aux immeubles, cours et modalités de travail : retour à la normale à compter du samedi 12 octobre. Complément d’information : Direction de la protection et de la prévention.

Satya Prakash

Academic title(s): 

Professor
Department of Biomedical Engineering
Artificial Cells and Organs Research Center

Member
Department of Physiology
Department of Experimental Medicine
Department of Experimental Surgery

Satya Prakash
Contact Information
Phone: 
514-398-3676
Fax number: 
514-398-7461
Address: 

Duff Medical Building
3775 University Street, Room 311
Montréal, QC  H3A 2B4

Email address: 
satya.prakash [at] mcgill.ca
Department: 
Biomedical Engineering
Areas of expertise: 

The primary research interest of this laboratory is in several innovative areas of artificial cells, microencapsulation, cell therapy, tissue engineering, nanomedicine, regenerative medicine, biomaterials, drug delivery, bacterial cell therapy, medical device engineering, and other biomedical technology developments. The research is focused on the development of new medical treatment strategies including novel cell and drug-based therapies.

Specifically, the research team is investigating cholesterol lowering formulations, fatty liver therapeutics, therapeutic protein delivery, novel therapies for neurodegenerative diseases, inflammatory bowel diseases, wound healing, and formulations for use in colon and breast cancers. The research team is also investigating basic mechanisms for the design of artificial organ substitutes such as artificial kidney, liver and skin. 

In recent years, the research team has contributed to the advancement and development of bioengineered, target specific, and controlled-release delivery systems. These systems are focused on designing artificial cell microcapsules to encapsulate mammalian cells, bacterial cells and other microorganisms, enzymes, small peptides, DNA and other active drugs. Such biotherapeutics are capable of targeting specific sites and are used in our research to design formulation for clinical applications.

In addition, the research team is developing systems that integrate bioengineering and tissue engineering principals, with gene and cell therapies, to design new therapeutic products. The present engineered formulations and devices have been applied in numerous areas including biomedicine, bioengineering, industry and clinical settings.

Research areas: 
Biomedical Sensors
Medical Diagnostics and Therapeutics
Biomolecular and Cellular Engineering
Area(s): 
Artificial Cells
Drug Delivery
Microbiome
Cancer
Biomedical Devices
Stem Cell Therapy
Probiotics
Metabolic Syndromes
Cardiovascular Health
Gastrointestinal Model
Back to top